|
1
|
Q TaoLS YoungCB WoodmanPG
MurrayEpstein-Barr virus (EBV) and its associated human cancers -
genetics, epigenetics, pathobiology and novel therapeuticsFront
Biosci1126722713200610.2741/200016720343
|
|
2
|
Q TaoAT ChanNasopharyngeal carcinoma:
molecular pathogenesis and therapeutic developmentsExpert Rev Mol
Med9124200717477889
|
|
3
|
MA MorrisCW DawsonLS YoungRole of the
Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the
pathogenesis of nasopharyngeal carcinomaFuture
Oncol5811825200910.2217/fon.09.5319663731
|
|
4
|
SW TsaoG TramoutanisCW DawsonAK LoDP
HuangThe significance of LMP1 expression in nasopharyngeal
carcinomaSemin Cancer
Biol12473487200210.1016/S1044579X0200090112450733
|
|
5
|
H ZhengLL LiDS HuXY DengY CaoRole of
Epstein-Barr virus encoded latent membrane protein 1 in the
carcinogenesis of nasopharyngeal carcinomaCell Mol
Immunol4185196200717601372
|
|
6
|
L DengJ YangXR ZhaoCells in G2/M phase
increased in human nasopharyngeal carcinoma cell line by EBV-LMP1
through activation of NF-kappaB and AP-1Cell
Res13187194200310.1038/sj.cr.729016312862319
|
|
7
|
T FaqingH ZhiY LiqunEpstein-Barr virus
LMP1 initiates cell proliferation and apoptosis inhibition via
regulating expression of survivin in nasopharyngeal carcinomaExp
Oncol2796101200515995625
|
|
8
|
Y SunG HegamyerYJ ChengAn infrequent point
mutation of the p53 gene in human nasopharyngeal carcinomaProc Natl
Acad Sci USA8965166520199210.1073/pnas.89.14.65161631151
|
|
9
|
CH Spruck IIIYC TsaiDP HuangAbsence of p53
gene mutations in primary nasopharyngeal carcinomasCancer
Res524787479019921511442
|
|
10
|
S MuronoT YoshizakiCS ParkM
FurukawaAssociation of Epstein-Barr virus infection with p53
protein accumulation but not bcl-2 protein in nasopharyngeal
carcinomaHistopathology34432438199910.1046/j.1365-2559.1999.00625.x10231418
|
|
11
|
LF SheuA ChenHS LeeHY HsuDS YuCooperative
interactions among p53, bcl-2 and Epstein-Barr virus latent
membrane protein 1 in nasopharyngeal carcinoma cellsPathol
Int54475485200410.1111/j.1440-1827.2004.01654.x15189500
|
|
12
|
L LiS ZhouX ChenThe activation of p53
mediated by Epstein-Barr virus latent membrane protein 1 in SV40
large T-antigen transformed cellsFEBS
Lett582755762200810.1016/j.febslet.2008.01.03118242176
|
|
13
|
L LiL GuoY TaoLatent membrane protein 1 of
Epstein-Barr virus regulates p53 phosphorylation through MAP
kinasesCancer
Lett255219231200710.1016/j.canlet.2007.04.01417582679
|
|
14
|
Y SunH YiPF ZhangIdentification of
differential proteins in nasopharyngeal carcinoma cells with p53
silence by proteome analysisFEBS
Lett581131139200710.1016/j.febslet.2006.12.00817184779
|
|
15
|
Y SunH YiY YangFunctional characterization
of p53 in nasopharyngeal carcinoma by stable shRNA expressionInt J
Oncol3410171027200919287958
|
|
16
|
G AmbrosiniC AdidaDC AltieriA novel
anti-apoptosis gene, survivin, expressed in cancer and lymphomaNat
Med3917921199710.1038/nm0897-9179256286
|
|
17
|
AC MitaMM MitaST NawrockiFJ GilesSurvivin:
key regulator of mitosis and apoptosis and novel target for cancer
therapeuticsClin Cancer
Res1450005005200810.1158/1078-0432.CCR-08-074618698017
|
|
18
|
A SuzukiM HayashidaT ItoSurvivin initiates
cell cycle entry by the competitive interaction with
Cdk4/p16(INK4a) and Cdk2/cyclin E complex
activationOncogene1932253234200010.1038/sj.onc.120366510918579
|
|
19
|
DS O’ConnorD GrossmanJ PlesciaRegulation
of apoptosis at cell division by p34cdc2 phosphorylation of
survivinProc Natl Acad Sci USA971310313107200011069302
|
|
20
|
WH HoffmanS BiadeJT ZilfouJ ChenM
MurphyTranscriptional repression of the anti-apoptotic survivin
gene by wild type p53J Biol
Chem27732473257200210.1074/jbc.M10664320011714700
|
|
21
|
A MirzaM McGuirkTN HockenberryHuman
survivin is negatively regulated by wild-type p53 and participates
in p53-dependent apoptotic
pathwayOncogene2126132622200210.1038/sj.onc.120535311965534
|
|
22
|
ML GulleyMP BurtonDC AllredEpstein-Barr
virus infection is associated with p53 accumulation in
nasopharyngeal carcinomaHum
Pathol29252259199810.1016/S0046-8177(98)90044-29496828
|
|
23
|
KW YipW ShiM PintiliePrognostic
significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in
nasopharyngeal cancerClin Cancer
Res1257265732200610.1158/1078-0432.CCR-06-057117020977
|
|
24
|
DC AltieriSurvivin, cancer networks and
pathway-directed drug discoveryNat Rev
Cancer86170200810.1038/nrc229318075512
|
|
25
|
K LohrC MoritzA ContenteM
Dobbelsteinp21/CDKN1A mediates negative regulation of transcription
by p53J Biol
Chem2783250732516200310.1074/jbc.M21251720012748190
|
|
26
|
M IkedaI OkamotoK TamuraDown-regulation of
survivin by ultraviolet C radiation is dependent on p53 and results
in G(2)-M arrest in A549 cellsCancer
Lett248292298200710.1016/j.canlet.2006.08.00516959403
|
|
27
|
Z WangS FukudaLM PelusSurvivin regulates
the p53 tumor suppressor gene
familyOncogene2381468153200410.1038/sj.onc.120799215361831
|
|
28
|
JE JungTK KimJS LeeSurvivin inhibits
anti-growth effect of p53 activated by aurora BBiochem Biophys Res
Commun33611641171200510.1016/j.bbrc.2005.08.23516171786
|
|
29
|
R KannangaiJ WangQZ LiuF SahinM
TorbensonSurvivin overexpression in hepatocellular carcinoma is
associated with p53 dysregulationInt J Gastrointest
Cancer355360200510.1385/IJGC:35:1:05315722574
|
|
30
|
CM ConnellR ColnaghiSP WheatleyNuclear
survivin has reduced stability and is not cytoprotectiveJ Biol
Chem28332893296200810.1074/jbc.M70446120018057009
|
|
31
|
CM ConnellSP WheatleyIA McNeishNuclear
survivin abrogates multiple cell cycle checkpoints and enhances
viral oncolysisCancer
Res6879237931200810.1158/0008-5472.CAN-08-081718829549
|
|
32
|
MD AiLL LiXR ZhaoY WuJP GongY
CaoRegulation of survivin and CDK4 by Epstein-Barr virus encoded
latent membrane protein 1 in nasopharyngeal carcinoma cell
linesCell Res15777784200510.1038/sj.cr.729034716246267
|
|
33
|
SW TsaoX WangY LiuEstablishment of two
immortalized nasopharyngeal epithelial cell lines using SV40 large
T and HPV16E6/E7 viral oncogenesBiochim Biophys
Acta1590150158200210.1016/S0167-4889(02)00208-212063178
|
